Literature DB >> 9265625

Structure-function analysis of Msx2-mediated transcriptional suppression.

E P Newberry1, T Latifi, J T Battaile, D A Towler.   

Abstract

Osteocalcin (OC) is a calcium binding protein expressed in mature osteoblasts undergoing mineralization. The OC gene has been identified as a target for transcriptional suppression by Msx2, a homeodomain transcription factor that controls ossification in calvarial bone of the developing skull. We have initiated systematic structure-function analyses of Msx2, using OC promoter suppression (luciferase reporter) in MC3T3-E1 calvarial osteoblasts as an assay. Msx2 variants were epitope ("FLAG")-tagged for monitoring Msx2 protein expression by Western blot analysis. Functional analyses of N- and C-terminally truncated molecules identify Msx2 residues 97-208 as the core suppressor domain. Internal deletion analyses indicate that suppressor function is dependent upon structural features encoded by residues 132-148--upstream of the homeodomain and overlapping the homeodomain N-terminal extension--but not upon residues in the three homeodomain helices. Mutations that enhance DNA binding activity do not proportionally enhance Msx2 suppressor function; moreover, a Msx2 point mutant Msx2(T147A) that completely lacks DNA binding activity is indistinguishable from wild-type Msx2 in its ability to suppress the OC promoter, demonstrating that direct interaction with DNA is not required for Msx2 suppressor function. This suggests that Msx2 suppresses transcription via protein-protein interactions with components of the basal transcriptional machinery, either alone or in concert with co-regulators. Using interaction "Far Western" blotting assays, we systematically tested for protein-protein interactions between Msx2 and components of the basal transcriptional machinery known to mediate transcriptional activation (TBP, TFIIB, and TFIIF). Msx2 binds both components of TFIIF (RAP74, RAP30), but not TFIIB or TBP. Msx2(55-208) encompasses core suppressor domain residues and binds TFIIF; in this context, deletion of the seventeen amino acid residues 132-148 that are required for core suppressor function abrogates interactions with TFIIF components. Co-expression of RAP74 in MC3T3-E1 cells partially reverses (>50%) suppression of OC promoter activity by Msx2, while co-expression of TFIIB or RAP30 has no effect. Thus the core suppressor domain of Msx2 participates in functionally important interactions with RAP74 that regulate OC promoter activity in calvarial osteoblasts.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9265625     DOI: 10.1021/bi971008x

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  19 in total

1.  Msx2 exerts bone anabolism via canonical Wnt signaling.

Authors:  Su-Li Cheng; Jian-Su Shao; Jun Cai; Oscar L Sierra; Dwight A Towler
Journal:  J Biol Chem       Date:  2008-05-15       Impact factor: 5.157

2.  The oncogenic potential of the Pax3-FKHR fusion protein requires the Pax3 homeodomain recognition helix but not the Pax3 paired-box DNA binding domain.

Authors:  P Y Lam; J E Sublett; A D Hollenbach; M F Roussel
Journal:  Mol Cell Biol       Date:  1999-01       Impact factor: 4.272

3.  The homeobox transcription factor MSX2 partially mediates the effects of bone morphogenetic protein 4 (BMP4) on somatic cell reprogramming.

Authors:  Lilong Lin; Lining Liang; Xiao Yang; Hao Sun; Yuan Li; Duanqing Pei; Hui Zheng
Journal:  J Biol Chem       Date:  2018-08-10       Impact factor: 5.157

4.  Physical dissection of the CCAAT/enhancer-binding protein alpha in regulating the mouse amelogenin gene.

Authors:  Yucheng Xu; Yan Larry Zhou; Robin L Erickson; Ormond A Macdougald; Malcolm L Snead
Journal:  Biochem Biophys Res Commun       Date:  2007-01-02       Impact factor: 3.575

5.  Conditional deletion of Msx homeobox genes in the uterus inhibits blastocyst implantation by altering uterine receptivity.

Authors:  Takiko Daikoku; Jeeyeon Cha; Xiaofei Sun; Susanne Tranguch; Huirong Xie; Tomoko Fujita; Yasushi Hirota; John Lydon; Francesco DeMayo; Robert Maxson; Sudhansu K Dey
Journal:  Dev Cell       Date:  2011-11-17       Impact factor: 12.270

6.  Loss of Msx2 function down-regulates the FoxE3 expression and results in anterior segment dysgenesis resembling Peters anomaly.

Authors:  Jiangyue Zhao; Kirio Kawai; Hongyan Wang; Di Wu; Mingwu Wang; Zhicao Yue; Jinsong Zhang; Yi-Hsin Liu
Journal:  Am J Pathol       Date:  2012-04-13       Impact factor: 4.307

7.  MSX2 mediates entry of human pluripotent stem cells into mesendoderm by simultaneously suppressing SOX2 and activating NODAL signaling.

Authors:  Qingqing Wu; Leisheng Zhang; Pei Su; Xiaohua Lei; Xin Liu; Hongtao Wang; Lisha Lu; Yang Bai; Tao Xiong; Dong Li; Zhengmao Zhu; Enkui Duan; Erlie Jiang; Sizhou Feng; Mingzhe Han; Yuanfu Xu; Fei Wang; Jiaxi Zhou
Journal:  Cell Res       Date:  2015-10-02       Impact factor: 25.617

8.  Regulation of proliferation in developing human tooth germs by MSX homeodomain proteins and cyclin-dependent kinase inhibitor p19INK4d.

Authors:  Darko Kero; Katarina Vukojevic; Petra Stazic; Danijela Sundov; Snjezana Mardesic Brakus; Mirna Saraga-Babic
Journal:  Organogenesis       Date:  2017-09-21       Impact factor: 2.500

9.  MSX2 inhibits the growth and migration of osteosarcoma cells by repressing SOX2.

Authors:  Yue Wu; Yi Jin; Norio Yamamoto; Akihiko Takeuchi; Shinji Miwa; Hiroyuki Tsuchiya; Zhijun Yang
Journal:  Am J Transl Res       Date:  2021-06-15       Impact factor: 4.060

10.  General transcription factor IIA-gamma increases osteoblast-specific osteocalcin gene expression via activating transcription factor 4 and runt-related transcription factor 2.

Authors:  Shibing Yu; Yu Jiang; Deborah L Galson; Min Luo; Yumei Lai; Yi Lu; Hong-Jiao Ouyang; Jian Zhang; Guozhi Xiao
Journal:  J Biol Chem       Date:  2008-01-02       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.